Health Status Outcomes
Current recommendations state those aged 55-69 with a prostate discuss the potential harms and potential benefits of prostate-specific antigen (PSA)-based screening for prostate cancer with a healthcare professional before deciding whether or not to be screened. For some men, there is a small potential benefit of screening to reduce the chance of death from prostate cancer.Related Health Status Outcomes Indicators: